"SPERO" の関連情報検索結果

How Spero Therapeutics Inc. stock reacts to inflationary pressures - Earnings Miss & Technical En...



How Spero Therapeutics Inc. stock reacts to inflationary pressures - Earnings Miss & Technical Entry and Exit Alerts  newser.com

Goleta-Based Startup Is Turning Plant Waste into Biofuel, with a Side of Vanilla - The Santa Barb...



Goleta-Based Startup Is Turning Plant Waste into Biofuel, with a Side of Vanilla  The Santa Barbara Independent

Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update ...



Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update  GlobeNewswire

Spero therapeutics CEO Rajavelu sells $95k in stock By Investing.com - Investing.com Nigeria



Spero therapeutics CEO Rajavelu sells $95k in stock By Investing.com  Investing.com Nigeria

Detecting price anomalies in Spero Therapeutics Inc. with AI - July 2025 Sector Moves & AI Enhanc...



Detecting price anomalies in Spero Therapeutics Inc. with AI - July 2025 Sector Moves & AI Enhanced Trading Alerts  newser.com

Will Spero Therapeutics Inc. stock deliver strong dividend growth - 2025 Dividend Review & Growth...



Will Spero Therapeutics Inc. stock deliver strong dividend growth - 2025 Dividend Review & Growth-Oriented Investment Plans  newser.com

Will Spero Therapeutics Inc. (2HA) stock benefit from sector leadership - 2025 Valuation Update &...



Will Spero Therapeutics Inc. (2HA) stock benefit from sector leadership - 2025 Valuation Update & Growth-Oriented Investment Plans  newser.com

Why Spero Therapeutics Inc. (2HA) stock is listed among top recommendations - July 2025 PreEarnin...



Why Spero Therapeutics Inc. (2HA) stock is listed among top recommendations - July 2025 PreEarnings & Fast Gaining Stock Reports  newser.com

Is Spero Therapeutics Inc. stock vulnerable to regulatory risks - July 2025 Market Mood & Advance...



Is Spero Therapeutics Inc. stock vulnerable to regulatory risks - July 2025 Market Mood & Advanced Technical Analysis Signals  newser.com

Will Spero Therapeutics Inc. (2HA) stock benefit from sector leadership - New Guidance & Safe Ent...



Will Spero Therapeutics Inc. (2HA) stock benefit from sector leadership - New Guidance & Safe Entry Trade Reports  newser.com

What recovery options are there for Spero Therapeutics Inc. - July 2025 Sentiment & Weekly Market...



What recovery options are there for Spero Therapeutics Inc. - July 2025 Sentiment & Weekly Market Pulse Alerts  newser.com

Will Spero Therapeutics Inc. stock sustain high P E ratios - 2025 Volatility Report & Weekly Cons...



Will Spero Therapeutics Inc. stock sustain high P E ratios - 2025 Volatility Report & Weekly Consistent Profit Watchlists  newser.com

Spero Therapeutics Inc. stock trendline breakdown - Weekly Trend Recap & Technical Analysis for T...



Spero Therapeutics Inc. stock trendline breakdown - Weekly Trend Recap & Technical Analysis for Trade Confirmation  newser.com

What does recent volatility data suggest for Spero Therapeutics Inc. - Market Weekly Review & Fas...



What does recent volatility data suggest for Spero Therapeutics Inc. - Market Weekly Review & Fast Moving Market Watchlists  newser.com

Will breakout in Spero Therapeutics Inc. lead to full recovery - 2025 Key Lessons & Capital Effic...



Will breakout in Spero Therapeutics Inc. lead to full recovery - 2025 Key Lessons & Capital Efficiency Focused Strategies  newser.com

How Spero Therapeutics Inc. stock reacts to inflationary pressures - Market Movement Recap & Free...



How Spero Therapeutics Inc. stock reacts to inflationary pressures - Market Movement Recap & Free Weekly Watchlist of Top Performers  newser.com

Spero Therapeutics Inc. stock trendline breakdown - 2025 Volatility Report & AI Powered Buy/Sell ...



Spero Therapeutics Inc. stock trendline breakdown - 2025 Volatility Report & AI Powered Buy/Sell Recommendations  newser.com

How sustainable is Spero Therapeutics Inc. stock dividend payout - 2025 Volatility Report & Long-...



How sustainable is Spero Therapeutics Inc. stock dividend payout - 2025 Volatility Report & Long-Term Growth Stock Strategies  newser.com

Detecting price anomalies in Spero Therapeutics Inc. with AI - Weekly Gains Summary & Step-by-Ste...



Detecting price anomalies in Spero Therapeutics Inc. with AI - Weekly Gains Summary & Step-by-Step Swing Trade Plans  newser.com

Spero Therapeutics Inc. stock daily chart insights - M&A Rumor & Stock Portfolio Risk Control - n...



Spero Therapeutics Inc. stock daily chart insights - M&A Rumor & Stock Portfolio Risk Control  newser.com

How Spero Therapeutics Inc. stock compares to industry benchmarks - Quarterly Earnings Report & L...



How Spero Therapeutics Inc. stock compares to industry benchmarks - Quarterly Earnings Report & Long Hold Capital Preservation Plans  newser.com

Detecting price anomalies in Spero Therapeutics Inc. with AI - July 2025 Decliners & Growth Orien...



Detecting price anomalies in Spero Therapeutics Inc. with AI - July 2025 Decliners & Growth Oriented Trading Recommendations  newser.com

Why Spero Therapeutics Inc. stock is favored by pension funds - July 2025 Outlook & High Accuracy...



Why Spero Therapeutics Inc. stock is favored by pension funds - July 2025 Outlook & High Accuracy Trade Alerts  newser.com

Anthony Michael "Tony" Spero's Obituary, Visitation & Funeral Information - Berna Funeral Homes



Anthony Michael "Tony" Spero's Obituary, Visitation & Funeral Information  Berna Funeral Homes

GSK unveils positive pivotal data for Spero's once-rejected oral antibiotic - Fierce Biotech



GSK unveils positive pivotal data for Spero's once-rejected oral antibiotic  Fierce Biotech

Is Spero Therapeutics Inc. stock vulnerable to regulatory risks - Swing Trade & Community Consens...



Is Spero Therapeutics Inc. stock vulnerable to regulatory risks - Swing Trade & Community Consensus Picks  newser.com

Will Spero Therapeutics Inc. stock deliver strong dividend growth - IPO Watch & Low Drawdown Inve...



Will Spero Therapeutics Inc. stock deliver strong dividend growth - IPO Watch & Low Drawdown Investment Strategies  newser.com

How Spero Therapeutics Inc. stock compares to industry benchmarks - Exit Point & Consistent Retur...



How Spero Therapeutics Inc. stock compares to industry benchmarks - Exit Point & Consistent Return Investment Signals  newser.com

Can Spero Therapeutics Inc. (2HA) stock test all time highs - Weekly Profit Summary & Step-by-Ste...



Can Spero Therapeutics Inc. (2HA) stock test all time highs - Weekly Profit Summary & Step-by-Step Swing Trade Plans  newser.com

Spero Therapeutics Reports Q3 2025 Financial Results - TipRanks



Spero Therapeutics Reports Q3 2025 Financial Results  TipRanks

Will Spero Therapeutics Inc. (2HA) stock benefit from sector leadership - M&A Rumor & Consistent ...



Will Spero Therapeutics Inc. (2HA) stock benefit from sector leadership - M&A Rumor & Consistent Growth Stock Picks  newser.com

Can Spero Therapeutics Inc. (2HA) stock test all time highs - Portfolio Performance Summary & Sho...



Can Spero Therapeutics Inc. (2HA) stock test all time highs - Portfolio Performance Summary & Short-Term High Return Ideas  newser.com

Will Spero Therapeutics Inc. (2HA) stock benefit from sector leadership - 2025 Major Catalysts & ...



Will Spero Therapeutics Inc. (2HA) stock benefit from sector leadership - 2025 Major Catalysts & Entry Point Confirmation Signals  newser.com

Spero Therapeutics earnings beat by $0.26, revenue fell short of estimates - Investing.com



Spero Therapeutics earnings beat by $0.26, revenue fell short of estimates  Investing.com

How Spero Therapeutics Inc. (2HA) stock behaves in tightening cycles - July 2025 Price Swings & R...



How Spero Therapeutics Inc. (2HA) stock behaves in tightening cycles - July 2025 Price Swings & Reliable Breakout Stock Forecasts  newser.com

Spero Therapeutics Q3 net loss narrows - TradingView



Spero Therapeutics Q3 net loss narrows  TradingView

Spero Therapeutics Focuses on Tebipenem HBr Program - TipRanks



Spero Therapeutics Focuses on Tebipenem HBr Program  TipRanks

Insights Ahead: Spero Therapeutics's Quarterly Earnings - Benzinga



Insights Ahead: Spero Therapeutics's Quarterly Earnings  Benzinga

Why Spero Therapeutics Inc. stock is favored by pension funds - Trade Risk Report & Weekly Sector...



Why Spero Therapeutics Inc. stock is favored by pension funds - Trade Risk Report & Weekly Sector Rotation Insights  newser.com

Barton School’s Spero Program Secures Funding for Year 2 Expansion - Wichita State University



Barton School’s Spero Program Secures Funding for Year 2 Expansion  Wichita State University

Will Spero Therapeutics Inc. stock deliver strong dividend growth - Quarterly Trade Review & Veri...



Will Spero Therapeutics Inc. stock deliver strong dividend growth - Quarterly Trade Review & Verified Entry Point Detection  newser.com

Is Spero Therapeutics Inc. stock vulnerable to regulatory risks - 2025 Valuation Update & Advance...



Is Spero Therapeutics Inc. stock vulnerable to regulatory risks - 2025 Valuation Update & Advanced Technical Analysis Signals  newser.com

CBS’s Spero Dedes Perfectly Summed Up Bears-Bengals Roller Coaster With His TD Calls - Sports Ill...



CBS’s Spero Dedes Perfectly Summed Up Bears-Bengals Roller Coaster With His TD Calls  Sports Illustrated

Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on ...



Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025  Yahoo Finance

How Spero Therapeutics Inc. stock compares to industry benchmarks - July 2025 Intraday Action & C...



How Spero Therapeutics Inc. stock compares to industry benchmarks - July 2025 Intraday Action & Capital Efficient Trading Techniques  newser.com

How Spero Therapeutics Inc. stock compares to industry benchmarks - Weekly Stock Report & Fast Mo...



How Spero Therapeutics Inc. stock compares to industry benchmarks - Weekly Stock Report & Fast Moving Stock Watchlists  newser.com

Spero Therapeutics Inc. stock daily chart insights - July 2025 Opening Moves & Consistent Income ...



Spero Therapeutics Inc. stock daily chart insights - July 2025 Opening Moves & Consistent Income Trade Ideas  newser.com

Will Spero Therapeutics Inc. (2HA) stock benefit from sector leadership - Quarterly Trade Review ...



Will Spero Therapeutics Inc. (2HA) stock benefit from sector leadership - Quarterly Trade Review & High Conviction Buy Zone Alerts  newser.com

Positive PIVOT-PO phase III data show tebipenem HBr’s potential as the first oral carbapenem anti...



Positive PIVOT-PO phase III data show tebipenem HBr’s potential as the first oral carbapenem antibiotic for patients with complicated urinary tract infections (cUTIs)  GSK

David Spero documentary, ‘The Heart of Rock and Roll,’ screens during Chagrin Documentary Film Fe...



David Spero documentary, ‘The Heart of Rock and Roll,’ screens during Chagrin Documentary Film Festival Oct.  Cleveland.com

What earnings margins imply for Spero Therapeutics Inc. (2HA) stock - July 2025 Decliners & AI Op...



What earnings margins imply for Spero Therapeutics Inc. (2HA) stock - July 2025 Decliners & AI Optimized Trading Strategy Guides  newser.com

Why Spero Therapeutics Inc. stock is favored by pension funds - Earnings Overview Summary & Real-...



Why Spero Therapeutics Inc. stock is favored by pension funds - Earnings Overview Summary & Real-Time Market Sentiment Reports  newser.com

Will Spero Therapeutics Inc. stock keep outperforming rivals - Breakout Watch & Smart Money Movem...



Will Spero Therapeutics Inc. stock keep outperforming rivals - Breakout Watch & Smart Money Movement Alerts  Fundação Cultural do Pará

GSK and Spero halt UTI antibiotic trial early due to high efficacy - Clinical Trials Arena



GSK and Spero halt UTI antibiotic trial early due to high efficacy  Clinical Trials Arena

Spero Therapeutics Q3 net loss narrows - MarketScreener



Spero Therapeutics Q3 net loss narrows  MarketScreener

GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win - Fierce Biotech



GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win  Fierce Biotech

How sustainable is Spero Therapeutics Inc. stock dividend payout - 2025 Market Trends & Weekly Ma...



How sustainable is Spero Therapeutics Inc. stock dividend payout - 2025 Market Trends & Weekly Market Pulse Updates  newser.com

How Spero Therapeutics Inc. stock compares to industry benchmarks - July 2025 Breakouts & Fast Ga...



How Spero Therapeutics Inc. stock compares to industry benchmarks - July 2025 Breakouts & Fast Gain Swing Alerts  newser.com

Spero Builds on First-Year Outcomes with New Class and Expanded Support - Wichita State University



Spero Builds on First-Year Outcomes with New Class and Expanded Support  Wichita State University

Will Spero Therapeutics Inc. (2HA) stock benefit from sector leadership - Quarterly Risk Review &...



Will Spero Therapeutics Inc. (2HA) stock benefit from sector leadership - Quarterly Risk Review & Daily Oversold Bounce Ideas  newser.com

Spero Therapeutics to Report Third Quarter 2025 Financial - GlobeNewswire



Spero Therapeutics to Report Third Quarter 2025 Financial  GlobeNewswire

Spero Therapeutics earnings beat by $0.26, revenue fell short of estimates - Investing.com Nigeria



Spero Therapeutics earnings beat by $0.26, revenue fell short of estimates  Investing.com Nigeria

Spero (NASDAQ: SPRO) to report third-quarter 2025 results Nov 13 after close; no call - Stock Titan



Spero (NASDAQ: SPRO) to report third-quarter 2025 results Nov 13 after close; no call  Stock Titan

Spero Therapeutics and GSK Announce Positive Results for Oral Tebipenem HBr in Phase 3 Trial for ...



Spero Therapeutics and GSK Announce Positive Results for Oral Tebipenem HBr in Phase 3 Trial for Complicated Urinary Tract Infections  Quiver Quantitative

Anthony "Tony" Michael Spero Obituary - Northwest Arkansas Democrat-Gazette



Anthony "Tony" Michael Spero Obituary  Northwest Arkansas Democrat-Gazette

GSK, Spero reveal full Phase 3 data for oral antibiotic, set for end-of-year filing - Endpoints News



GSK, Spero reveal full Phase 3 data for oral antibiotic, set for end-of-year filing  Endpoints News

IHG Hotels & Resorts introduces Hotel Spero, Vignette Collection, in San Francisco - InterContine...



IHG Hotels & Resorts introduces Hotel Spero, Vignette Collection, in San Francisco  InterContinental Hotels Group PLC

Farmington man dies in Baxter County crash, according to Sheriff’s Office - Northwest Arkansas De...



Farmington man dies in Baxter County crash, according to Sheriff’s Office  Northwest Arkansas Democrat-Gazette

Springdale firefighter killed in off-duty ATV crash - 5newsonline.com



Springdale firefighter killed in off-duty ATV crash  5newsonline.com

Is Spero Therapeutics Inc. (2HA) stock undervalued historically - Portfolio Update Summary & Dail...



Is Spero Therapeutics Inc. (2HA) stock undervalued historically - Portfolio Update Summary & Daily Stock Momentum Reports  newser.com

Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek - GlobeNewswire



Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek  GlobeNewswire

The Blogs: Whispering Israel in New York City | Harper Spero - The Times of Israel



The Blogs: Whispering Israel in New York City | Harper Spero  The Times of Israel

Obituary for Spero Leo Mengos - Baird Funeral Home



Obituary for Spero Leo Mengos  Baird Funeral Home

Spero therapeutics CEO Rajavelu sells $95k in stock - Investing.com India



Spero therapeutics CEO Rajavelu sells $95k in stock  Investing.com India

Barton School's Micro-Credential Programs Recognized as the First of Their Kind in the World - Wi...



Barton School's Micro-Credential Programs Recognized as the First of Their Kind in the World  Wichita State University

Spero and ROE reopen Murphysboro campus with new purpose - Southern Illinoisan



Spero and ROE reopen Murphysboro campus with new purpose  Southern Illinoisan

Is Spero Therapeutics Inc. (2HA) stock undervalued historically - GDP Growth & Verified Trade Ide...



Is Spero Therapeutics Inc. (2HA) stock undervalued historically - GDP Growth & Verified Trade Idea Suggestions  newser.com

Spero Therapeutics, Inc. (NASDAQ:SPRO) Held Back By Insufficient Growth Even After Shares Climb 2...



Spero Therapeutics, Inc. (NASDAQ:SPRO) Held Back By Insufficient Growth Even After Shares Climb 26%  Sahm

Spero James Makris Obituary | October 20, 2025 - Hartford Courant



Spero James Makris Obituary | October 20, 2025  Hartford Courant

Spero (NASDAQ: SPRO) pivotal trial stopped early, noninferiority met, Q4 2025 filing - Stock Titan



Spero (NASDAQ: SPRO) pivotal trial stopped early, noninferiority met, Q4 2025 filing  Stock Titan

GSK, Spero stop UTI drug trial after early success - Reuters



GSK, Spero stop UTI drug trial after early success  Reuters

Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study - GlobeNewswire



Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study  GlobeNewswire

Spero halts development on another antibiotic in latest reprioritization - Fierce Biotech



Spero halts development on another antibiotic in latest reprioritization  Fierce Biotech

From big stage to small screen: How one marketer turns live theater into social media fodder - Ma...



From big stage to small screen: How one marketer turns live theater into social media fodder  Marketing Brew

Franklin Holland Spero Obituary (2025) - Evanston, WY - Crandall Funeral Home - Evanston - Legacy



Franklin Holland Spero Obituary (2025) - Evanston, WY - Crandall Funeral Home - Evanston  Legacy

Down 17.7% in 4 Weeks, Here's Why Spero Therapeutics (SPRO) Looks Ripe for a Turnaround - Yahoo F...



Down 17.7% in 4 Weeks, Here's Why Spero Therapeutics (SPRO) Looks Ripe for a Turnaround  Yahoo Finance

Phase 3 PIVOT-PO: Spero Therapeutics to present oral tebipenem HBr cUTI data at IDWeek Oct 20 - S...



Phase 3 PIVOT-PO: Spero Therapeutics to present oral tebipenem HBr cUTI data at IDWeek Oct 20  Stock Titan

Reverie, Georgetown’s Only Michelin-Starred Restaurant, Is Closing - Eater DC



Reverie, Georgetown’s Only Michelin-Starred Restaurant, Is Closing  Eater DC

The Blogs: One Foot Here, One Foot There | Harper Spero - The Times of Israel



The Blogs: One Foot Here, One Foot There | Harper Spero  The Times of Israel

Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update...



Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update  Yahoo Finance

Kathleen Spero Obituary March 22, 2024 - Bond Funeral Home



Kathleen Spero Obituary March 22, 2024  Bond Funeral Home

Spero Therapeutics And 2 Other Promising Penny Stocks To Watch - Yahoo Finance



Spero Therapeutics And 2 Other Promising Penny Stocks To Watch  Yahoo Finance

GSK and Spero's oral antibiotic succeeds in pivotal UTI study - FirstWord Pharma



GSK and Spero's oral antibiotic succeeds in pivotal UTI study  FirstWord Pharma

Anthony Spero Obituary (2025) - Legacy



Anthony Spero Obituary (2025)  Legacy

GSK, Spero share data behind early study stop for oral antibiotic - FirstWord Pharma



GSK, Spero share data behind early study stop for oral antibiotic  FirstWord Pharma

Paula A.C. Spero Obituary (2025) - Parkville, MD - The Baltimore Banner - Legacy



Paula A.C. Spero Obituary (2025) - Parkville, MD - The Baltimore Banner  Legacy

As government pauses resettling refugees, this OKC group is raising money for those already here ...



As government pauses resettling refugees, this OKC group is raising money for those already here  The Oklahoman

Cedar Lee Theatre to offer free screening of new David Spero documentary to bring people back to ...



Cedar Lee Theatre to offer free screening of new David Spero documentary to bring people back to the district  News 5 Cleveland WEWS

Spero Dedes reveals his broadcast team’s group chat is called ‘AFC South Crew’ - Awful Announcing



Spero Dedes reveals his broadcast team’s group chat is called ‘AFC South Crew’  Awful Announcing

Gerardo Spero appointed Federal Security Director for Pennsylvania and Delaware - tsa.gov



Gerardo Spero appointed Federal Security Director for Pennsylvania and Delaware  tsa.gov